News

Filter

Current filters:

Merck & CoReproductive

US ANDAs filed for generic Beyaz, Isentress and Epivir

12-01-2012

The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

Merck & Co debuts Nexplanon in USA; gets negative FDA response on Zoely and Saflutan

10-11-2011

Merck & Co (NYSE; MRK), the USA’s second largest drugmaker, says that its Nexplanon (etonogestrel…

DiabetesJanuviaMarkets & MarketingMerck & CoNexplanonOphthalmicsPharmaceuticalRegulationReproductiveResearchSaflutanZoely

Single fertility treatment with Merck & Co’s Elonva produced live birth rates comparable to daily rFSH Injections

30-06-2010

US drug giant Merck & Co’s subsidiary MSD has announced findings from a follow-up study to the pivotal…

ElonvaMerck & CoPharmaceuticalReproductiveResearch

US Coalition for Vaccine Safety takes another swipe at regulators, this time over Merck & Co’s Gardasil

20-05-2010

The USA’s Coalition for Vaccine Safety claims that a three-part investigative series on US drug…

GardasilMerck & CoNorth AmericaPharmaceuticalPoliticsRegulationReproductiveVaccines

Back to top